Women with MS were significantly less exposed to DMTs compared with men. Anticipation of pregnancy was probably an important factor underlying this difference, but also sex-specific therapeutic inertia. Neurologists and patients should be educated on the most recent recommendations on the use of DMTs in the context of pregnancy to avoid deleterious therapeutic inertia.
Author(s):
Gavoille A, Leray E, Marignier R, Rollot F, Casey R, Mathey G, et al.
References including authors:
Gavoille A, Leray E, Marignier R, Rollot F, Casey R, Mathey G, et al. Sex‑Related Gap in the Use of Disease‑Modifying Therapies in Multiple Sclerosis. Neurology. 2025 Aug 26;105(4):e213907. doi:10.1212/WNL.0000000000213907